Helen Susan Kim, EVP, Business Development at Kite Pharma, Inc. (KITE), sold 10,845 shares at $111.60 ($1.2M) on 2017-07-31, disclosed to the SEC on 2017-08-01.
Open-market sale of $1.2M KITE by EVP, Business Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $109.74 | 7,448 | $817K | 68.5% |
| 2 | $110.55 | 2,725 | $301K | 25.2% |
| 3 | $111.60 | 672 | $75K | 6.3% |
| Total | $110.06 avg | 10,845 | $1.2M | 100% |
| Filing → |
| AMTI | SELL | 2021-08-25 | $585K | — | Filing → |
| AMTI | SELL | 2021-07-06 | $17.3M | — | Filing → |
| KITE | SELL | 2017-09-27 | $1.1M | — | Filing → |